![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nexmed (MM) | NASDAQ:NEXM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.38 | 0 | 01:00:00 |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
|||
FORM
8-K
|
|||
CURRENT
REPORT
|
|||
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of
1934
|
|||
Date
of Report (Date of earliest event reported): September 10,
2010
|
|||
Apricus
Biosciences, Inc.
|
|||
(Exact
name of registrant as specified in its
charter)
|
Nevada
|
0-22245
|
87-0449967
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
6330
Nancy Ridge Drive, Suite 103, San Diego, California
|
92121
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code (858)
222-8041
|
|
NexMed,
Inc.
|
|
(Former
name or former address, if changed since last report.)
|
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
|
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13a-4(c))
|
Exhibit
No.
|
Description
|
|
3.1
3.2
|
Certificate
of Amendment to Articles of Incorporation
Amended
and Restated Bylaws
|
Apricus
Biosciences, Inc.
|
|||
By:
|
/s/
Mark Westgate
|
||
Name:
Mark Westgate
|
|||
Title:
Vice President and Chief Financial
Officer
|
1 Year Nexmed (MM) Chart |
1 Month Nexmed (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions